These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 8132824)

  • 1. Distribution of the matrix metalloproteinases stromelysin, gelatinases A and B, and collagenase in Crohn's disease and normal intestine.
    Bailey CJ; Hembry RM; Alexander A; Irving MH; Grant ME; Shuttleworth CA
    J Clin Pathol; 1994 Feb; 47(2):113-6. PubMed ID: 8132824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The distribution of matrix metalloproteinases and tissue inhibitor of metalloproteinases in colorectal cancer.
    Gallegos NC; Smales C; Savage FJ; Hembry RM; Boulos PB
    Surg Oncol; 1995; 4(2):111-9. PubMed ID: 7551259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct expression profiles of stromelysin-2 (MMP-10), collagenase-3 (MMP-13), macrophage metalloelastase (MMP-12), and tissue inhibitor of metalloproteinases-3 (TIMP-3) in intestinal ulcerations.
    Vaalamo M; Karjalainen-Lindsberg ML; Puolakkainen P; Kere J; Saarialho-Kere U
    Am J Pathol; 1998 Apr; 152(4):1005-14. PubMed ID: 9546361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The distribution of matrix metalloproteinases and tissue inhibitor of metalloproteinases in colorectal cancer.
    Gallegos NC; Smales C; Savage FJ; Hembry RM; Boulos PB
    Surg Oncol; 1995 Feb; 4(1):21-9. PubMed ID: 7780609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chondrocyte cultures express matrix metalloproteinase mRNA and immunoreactive protein; stromelysin-1 and 72 kDa gelatinase are localized in extracellular matrix vesicles.
    Schmitz JP; Dean DD; Schwartz Z; Cochran DL; Grant GM; Klebe RJ; Nakaya H; Boyan BD
    J Cell Biochem; 1996 Jun; 61(3):375-91. PubMed ID: 8761942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased mucosal matrix metalloproteinase-1, -2, -3 and -9 activity in patients with inflammatory bowel disease and the relation with Crohn's disease phenotype.
    Meijer MJ; Mieremet-Ooms MA; van der Zon AM; van Duijn W; van Hogezand RA; Sier CF; Hommes DW; Lamers CB; Verspaget HW
    Dig Liver Dis; 2007 Aug; 39(8):733-9. PubMed ID: 17602907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced expression of matrilysin, collagenase, and stromelysin-1 in gastrointestinal ulcers.
    Saarialho-Kere UK; Vaalamo M; Puolakkainen P; Airola K; Parks WC; Karjalainen-Lindsberg ML
    Am J Pathol; 1996 Feb; 148(2):519-26. PubMed ID: 8579114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A major role for matrix metalloproteinases in T cell injury in the gut.
    Pender SL; Tickle SP; Docherty AJ; Howie D; Wathen NC; MacDonald TT
    J Immunol; 1997 Feb; 158(4):1582-90. PubMed ID: 9029093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of the levels of human trabecular matrix metalloproteinases and inhibitor by interleukin-1 and dexamethasone.
    Samples JR; Alexander JP; Acott TS
    Invest Ophthalmol Vis Sci; 1993 Nov; 34(12):3386-95. PubMed ID: 8225873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imbalance of stromelysin-1 and TIMP-1 in the mucosal lesions of children with inflammatory bowel disease.
    Heuschkel RB; MacDonald TT; Monteleone G; Bajaj-Elliott M; Smith JA; Pender SL
    Gut; 2000 Jul; 47(1):57-62. PubMed ID: 10861265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of matrix metalloproteinases by N-carboxyalkyl peptides.
    Chapman KT; Kopka IE; Durette PL; Esser CK; Lanza TJ; Izquierdo-Martin M; Niedzwiecki L; Chang B; Harrison RK; Kuo DW
    J Med Chem; 1993 Dec; 36(26):4293-301. PubMed ID: 8277511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques.
    Galis ZS; Sukhova GK; Lark MW; Libby P
    J Clin Invest; 1994 Dec; 94(6):2493-503. PubMed ID: 7989608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunolocalization of matrix metallo-proteinases and their tissue inhibitor in human mammary pathology.
    Clavel C; Polette M; Doco M; Binninger I; Birembaut P
    Bull Cancer; 1992; 79(3):261-70. PubMed ID: 1392165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of matrix metalloproteinases and inhibitor by human retinal pigment epithelium.
    Alexander JP; Bradley JM; Gabourel JD; Acott TS
    Invest Ophthalmol Vis Sci; 1990 Dec; 31(12):2520-8. PubMed ID: 2176183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of matrix metalloproteinases in a model of T cell mediated tissue injury in the gut: analysis by gene array and in situ hybridisation.
    Salmela MT; MacDonald TT; Black D; Irvine B; Zhuma T; Saarialho-Kere U; Pender SL
    Gut; 2002 Oct; 51(4):540-7. PubMed ID: 12235077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced expression of interstitial collagenase, stromelysin-1, and urokinase plasminogen activator in lesions of dermatitis herpetiformis.
    Airola K; Vaalamo M; Reunala T; Saarialho-Kere UK
    J Invest Dermatol; 1995 Aug; 105(2):184-9. PubMed ID: 7636299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas.
    Nakano A; Tani E; Miyazaki K; Yamamoto Y; Furuyama J
    J Neurosurg; 1995 Aug; 83(2):298-307. PubMed ID: 7616276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix metalloproteinases and TIMP-1 localization at sites of osteogenesis in the craniofacial region of the rabbit embryo.
    Breckon JJ; Hembry RM; Reynolds JJ; Meikle MC
    Anat Rec; 1995 Jun; 242(2):177-87. PubMed ID: 7668402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 92K-GL (MMP-9) and 72K-GL (MMP-2) are produced in vivo by human oral squamous cell carcinomas and can enhance FIB-CL (MMP-1) activity in vitro.
    Pickett KL; Harber GJ; DeCarlo AA; Louis P; Shaneyfelt S; Windsor LJ; Bodden MK
    J Dent Res; 1999 Jul; 78(7):1354-61. PubMed ID: 10403463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of multiple matrix metalloproteinases and urokinase type plasminogen activator in cultured Kaposi sarcoma cells.
    Meade-Tollin LC; Way D; Witte MH
    Acta Histochem; 1999 Jul; 101(3):305-16. PubMed ID: 10443293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.